Latest filing published 22 May 2026 for 리센스메디컬.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -64.7%Entry ₩24,200 · Close 07 Oct 2026 ₩8,540
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
김건호: trading record in brief
This profile gathers the share dealings of 김건호 in 리센스메디컬, where the filings describe the role as chief executive. In total, 3 filings cover trades dated 31 March 2026.
Every open-market trade on record is a purchase: 3 purchases, and no sale. The amount is not disclosed for 3 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The record was last updated on 22 May 2026 with an open-market purchase in 리센스메디컬. Between a trade and the moment it shows up on DART (FSS), the median delay is 7 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 김건호
Open company profiles for insider transactions, fundamentals and analyst consensus when available.